CLINICAL_TRIALS
trial_result
· 2023-10-04
Clinical Trial Update: Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents [Phase 2]
Summary
Phase 2 trial of Ecopipam tablets for Tourette syndrome in children and adolescents completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emalex Biosciences Inc. | Conditions: Tourette Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2023-10-04